Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide 3‑kinase/protein kinase B pathway

Zhang,Baichao; Yin,Xiaoning; Sui,Shaoguang

doi:10.3892/or.2018.6648

Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide 3‑kinase/protein kinase B pathway

Authors:
- Baichao Zhang
- Xiaoning Yin
- Shaoguang Sui
View Affiliations

Affiliations: General Department, Zuanshiwan Hospital District of The Second Hospital of Dalian Medical University, Dalian, Liaoning 116000, P.R. China, Emergency Department, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116000, P.R. China
Published online on: August 17, 2018 https://doi.org/10.3892/or.2018.6648
Pages: 2758-2765

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Resveratrol, a natural product, has been revealed to exert antitumor effects in multiple types of tumors. However, the antitumor effects of resveratrol on hepatocellular carcinoma (HCC) and its potential underlying mechanisms have not yet been elucidated. The present study demonstrated that resveratrol inhibited viability, proliferation, invasion and migration of HCC cells significantly in a time‑ and dose‑dependent manner, indicating that resveratrol exerted antitumor effects in HCC. Furthermore, relative expression of autophagy‑related proteins Beclin1 and LC3 II/I ratio was increased while p62 expression was decreased by resveratrol treatment dose‑dependently. The LC3+ puncta formation, which represented autophagosome formation was also markedly dose‑dependently upregulated by resveratrol treatment, suggesting that resveratrol induced autophagy in HCC cells. In addition, treatment with autophagy inhibitor 3‑methyladenine (3‑MA) counteracted the inhibitory effect of resveratrol on HCC cell proliferation, invasion and migration, indicating that suppressing autophagy may hamper the antitumor effect of resveratrol in HCC. It was revealed that resveratrol upregulated the expression of p53 while decreasing the ratio of phosphorylated protein kinase B (p‑Akt)/Akt in HCC cells. Treatment with p53 inhibitor pifithrin‑α and Akt activator insulin‑like growth factor‑1 decreased the expression of Beclin1 while significantly promoting cell proliferation, invasion and migration compared with the resveratrol treatment group. Taken together, the results of the present study revealed that resveratrol inhibited the proliferation and mobility of HCC cells through inducing autophagy via activating p53 and inhibiting phosphoinositide 3‑kinase/Akt. Enhancing autophagy can augment the antitumor effects of resveratrol in HCC. Therefore, combining resveratrol with an autophagy inducer may be a viable option for treating HCC.

View Figures

View References

1	Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
2	Dugo EB, Yedjou CG, Stevens JJ and Tchounwou PB: Therapeutic potential of arsenic trioxide (ATO) in treatment of hepatocellular carcinoma: Role of oxidative stress in ATO-induced apoptosis. Ann Clin Pathol. 5:11012017.PubMed/NCBI
3	Oh IS, Sinn DH, Kang TW, Lee MW, Kang W, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, et al: Liver function assessment using albumin-bilirubin grade for patients with very early-stage hepatocellular carcinoma treated with radiofrequency ablation. Dig Dis Sci. 62:3235–3242. 2017. View Article : Google Scholar : PubMed/NCBI
4	Kanda T, Ogasawara S, Chiba T, Haga Y, Omata M and Yokosuka O: Current management of patients with hepatocellular carcinoma. World J Hepatol. 7:1913–1920. 2015. View Article : Google Scholar : PubMed/NCBI
5	Gomha SM, Edrees MM, Muhammad ZA and El-Reedy AA: 5-(Thiophen-2-yl)-1,3,4-thiadiazole derivatives: Synthesis, molecular docking and in vitro cytotoxicity evaluation as potential anticancer agents. Drug Des Dev Ther. 12:1511–1523. 2018. View Article : Google Scholar
6	Rawat D, Shrivastava S, Naik RA, Chhonker SK, Mehrotra A and Koiri RK: An overview of natural plant products in the treatment of hepatocellular carcinoma. Anticancer Agents Med Chem. Jun 3–2018.(Epub ahead of print). doi: 10.2174/1871520618666180604085612. View Article : Google Scholar
7	Piotrowska H, Kucinska M and Murias M: Biological activity of piceatannol: Leaving the shadow of resveratrol. Mutat Res. 750:60–82. 2012. View Article : Google Scholar : PubMed/NCBI
8	Johnson WD, Morrissey RL, Usborne AL, Kapetanovic I, Crowell JA, Muzzio M and McCormick DL: Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity. Food Chem Toxicol. 49:3319–3327. 2011. View Article : Google Scholar : PubMed/NCBI
9	Szekeres T, Saiko P, Fritzer-Szekeres M, Djavan B and Jager W: Chemopreventive effects of resveratrol and resveratrol derivatives. Ann NY Acad Sci. 1215:89–95. 2011. View Article : Google Scholar : PubMed/NCBI
10	Fabre KM, Saito K, DeGraff W, Sowers AL, Thetford A, Cook JA, Krishna MC and Mitchell JB: The effects of resveratrol and selected metabolites on the radiation and antioxidant response. Cancer Biol Ther. 12:915–923. 2011. View Article : Google Scholar : PubMed/NCBI
11	Kunimasa K, Ohta T, Tani H, Kato E, Eguchi R, Kaji K, Ikeda K, Mori H, Mori M, Tatefuji T, et al: Resveratrol derivative-rich melinjo (Gnetum gnemon L.) seed extract suppresses multiple angiogenesis-related endothelial cell functions and tumor angiogenesis. Mol Nutri Food Res. 55:1730–1734. 2011. View Article : Google Scholar
12	Li Q, Yue Y, Chen L, Xu C, Wang Y, Du L, Xue X, Liu Q, Wang Y and Fan F: Resveratrol sensitizes carfilzomib-induced apoptosis via promoting oxidative stress in multiple myeloma cells. Front Pharmacol. 9:3342018. View Article : Google Scholar : PubMed/NCBI
13	Fan Y, Chiu JF, Liu J, Deng Y, Xu C, Zhang J and Li G: Resveratrol induces autophagy-dependent apoptosis in HL-60 cells. BMC Cancer. 18:5812018. View Article : Google Scholar : PubMed/NCBI
14	Chang CH, Lee CY, Lu CC, Tsai FJ, Hsu YM, Tsao JW, Juan YN, Chiu HY, Yang JS and Wang CC: Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling. Int J Oncol. 50:873–882. 2017. View Article : Google Scholar : PubMed/NCBI
15	Mizushima N: Autophagy: Process and function. Genes Dev. 21:2861–2873. 2007. View Article : Google Scholar : PubMed/NCBI
16	Fan TF, Bu LL, Wang WM, Ma SR, Liu JF, Deng WW, Mao L, Yu GT, Huang CF, Liu B, et al: Tumor growth suppression by inhibiting both autophagy and STAT3 signaling in HNSCC. Oncotarget. 6:43581–43593. 2015. View Article : Google Scholar : PubMed/NCBI
17	Singh SK, Banerjee S, Acosta EP, Lillard JW and Singh R: Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/p21^WAF1/CIP1 and p27^KIP1 pathway. Oncotarget. 8:17216–17228. 2017. View Article : Google Scholar : PubMed/NCBI
18	Chai R, Fu H, Zheng Z, Liu T, Ji S and Li G: Resveratrol inhibits proliferation and migration through SIRT1 mediated posttranslational modification of PI3K/AKT signaling in hepatocellular carcinoma cells. Mol Med Rep. 16:8037–8044. 2017. View Article : Google Scholar : PubMed/NCBI
19	Harikumar KB, Kunnumakkara AB, Sethi G, Diagaradjane P, Anand P, Pandey MK, Gelovani J, Krishnan S, Guha S and Aggarwal BB: Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer. 127:257–268. 2010.PubMed/NCBI
20	Bai Y, Mao QQ, Qin J, Zheng XY, Wang YB, Yang K, Shen HF and Xie LP: Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci. 101:488–493. 2010. View Article : Google Scholar : PubMed/NCBI
21	Ko JH, Sethi G, Um JY, Shanmugam MK, Arfuso F, Kumar AP, Bishayee A and Ahn KS: The role of resveratrol in cancer therapy. Int J Mol Sci. 18:E25892017. View Article : Google Scholar : PubMed/NCBI
22	Bai Y, Yang H, Zhang G, Hu L, Lei Y, Qin Y, Yang Y, Wang Q, Li R and Mao Q: Inhibitory effects of resveratrol on the adhesion, migration and invasion of human bladder cancer cells. Mol Med Rep. 15:885–889. 2017. View Article : Google Scholar : PubMed/NCBI
23	Mizushima N and Komatsu M: Autophagy: Renovation of cells and tissues. Cell. 147:728–741. 2011. View Article : Google Scholar : PubMed/NCBI
24	Guo JY, Xia B and White E: Autophagy-mediated tumor promotion. Cell. 155:1216–1219. 2013. View Article : Google Scholar : PubMed/NCBI
25	Lamy L, Ngo VN, Emre NC, Shaffer AL III, Yang Y, Tian E, Nair V, Kruhlak MJ, Zingone A, Landgren O, et al: Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell. 23:435–449. 2013. View Article : Google Scholar : PubMed/NCBI
26	Mariño G, Niso-Santano M, Baehrecke EH and Kroemer G: Self-consumption: The interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 15:81–94. 2014. View Article : Google Scholar : PubMed/NCBI
27	Kadowaki M and Karim MR: Cytosolic LC3 ratio as a quantitative index of macroautophagy. Methods Enzymol. 452:199–213. 2009. View Article : Google Scholar : PubMed/NCBI
28	Wang S, Wang C, Yan F, Wang T, He Y, Li H, Xia Z and Zhang Z: N-acetylcysteine attenuates diabetic myocardial ischemia reperfusion injury through inhibiting excessive autophagy. Mediators Inflamm. 2017:92572912017. View Article : Google Scholar : PubMed/NCBI
29	Zhu H, Ding J, Wu J, Liu T, Liang J, Tang Q and Jiao M: Resveratrol attenuates bone cancer pain through regulating the expression levels of ASIC3 and activating cell autophagy. Acta Biochim Biophys Sin. 49:1008–1014. 2017. View Article : Google Scholar : PubMed/NCBI
30	Lang F, Qin Z, Li F, Zhang H, Fang Z and Hao E: Apoptotic cell death induced by resveratrol is partially mediated by the autophagy pathway in human ovarian cancer cells. PLoS One. 10:e01291962015. View Article : Google Scholar : PubMed/NCBI
31	He W and Cheng Y: Inhibition of miR-20 promotes proliferation and autophagy in articular chondrocytes by PI3K/AKT/mTOR signaling pathway. Biomed Pharmacother. 97:607–615. 2018. View Article : Google Scholar : PubMed/NCBI
32	Deng F, Ma YX, Liang L, Zhang P and Feng J: The pro-apoptosis effect of sinomenine in renal carcinoma via inducing autophagy through inactivating PI3K/AKT/mTOR pathway. Biomed Pharmacother. 97:1269–1274. 2018. View Article : Google Scholar : PubMed/NCBI
33	Huang SW, Chang SH, Mu SW, Jiang HY, Wang ST, Kao JK, Huang JL, Wu CY, Chen YJ and Shieh JJ: Imiquimod activates p53-dependent apoptosis in a human basal cell carcinoma cell line. J Dermatol Sci. 81:182–191. 2016. View Article : Google Scholar : PubMed/NCBI